Novabay Pharmaceuticals Investor Relations Material
Latest events
EGM 2024
Novabay Pharmaceuticals
Q1 2025
14 May, 2025
Q4 2024
2 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novabay Pharmaceuticals Inc
Access all reports
NovaBay Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative products for the eye care market. The company specializes in creating novel, fast-acting, synthetic anti-infectives designed to mimic the body’s natural defense mechanisms against infection. Its product portfolio includes solutions for eye care, such as Avenova, an antimicrobial lid and lash solution, as well as products for wound care and skincare. The company is headquartered in Emeryville, California, and its shares are listed on the NYSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NBY
Country
🇺🇸 United States